PMC:7461420 / 61046-61146 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T284","span":{"begin":58,"end":62},"obj":"Disease"}],"attributes":[{"id":"A284","pred":"mondo_id","subj":"T284","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"A library of small peptide‐anilides was developed as anti‐SARS‐CoV‐1 Mpro agents (77–80; Figure 23)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T779","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T780","span":{"begin":19,"end":26},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"A library of small peptide‐anilides was developed as anti‐SARS‐CoV‐1 Mpro agents (77–80; Figure 23)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43478","span":{"begin":19,"end":26},"obj":"Chemical"}],"attributes":[{"id":"A3486","pred":"chebi_id","subj":"T43478","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"A library of small peptide‐anilides was developed as anti‐SARS‐CoV‐1 Mpro agents (77–80; Figure 23)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1853","span":{"begin":69,"end":73},"obj":"Gene"},{"id":"1857","span":{"begin":58,"end":66},"obj":"Species"},{"id":"1858","span":{"begin":19,"end":35},"obj":"Chemical"}],"attributes":[{"id":"A1853","pred":"tao:has_database_id","subj":"1853","obj":"Gene:8673700"},{"id":"A1857","pred":"tao:has_database_id","subj":"1857","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A library of small peptide‐anilides was developed as anti‐SARS‐CoV‐1 Mpro agents (77–80; Figure 23)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T528","span":{"begin":0,"end":100},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A library of small peptide‐anilides was developed as anti‐SARS‐CoV‐1 Mpro agents (77–80; Figure 23)."}